-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Nika Pharmaceuticals, Inc quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2021 to Q1 2024.
- Nika Pharmaceuticals, Inc Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$150K, a 667% decline year-over-year.
- Nika Pharmaceuticals, Inc annual Net Cash Provided by (Used in) Operating Activities for 2023 was $64.8K, a 92.3% increase from 2022.
- Nika Pharmaceuticals, Inc annual Net Cash Provided by (Used in) Operating Activities for 2022 was $33.7K, a 129% increase from 2021.
- Nika Pharmaceuticals, Inc annual Net Cash Provided by (Used in) Operating Activities for 2021 was $14.7K.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)